Simple Summary One of the most important abilities of a tumor is to establish a state of
immunosuppression inside the tumor microenvironment. This is made possible through …

Hepatocellular carcinoma (HCC) is a prevalent disease with a progression that is modulated
by the immune system. Systemic therapy is used in the advanced stage and until 2017 …

Advanced hepatocellular carcinoma (HCC) is the most frequent liver cancer. Immunotherapy
has been explored in this disease in order to improve survival outcomes. Nowadays …

Hepatocellular carcinoma (HCC) is one of the most deadly and rapidly evolving cancers
worldwide. The current systemic treatment strategies in advanced tumor stages remain …

Due to its widespread occurrence and high mortality rate, hepatocellular carcinoma (HCC) is
an abhorrent kind of cancer. Immunotherapy is a hot spot in the field of cancer treatment …

Hepatocellular carcinoma (HCC) arises on the background of chronic liver disease. Despite
the development of effective anti-viral therapeutics HCC is continuing to rise, in part driven …

Immunotherapy is a promising approach to treating various types of cancers, including
hepatocellular carcinoma (HCC). While single immunotherapy drugs show limited …

Hepatocellular carcinoma (HCC) is considered an immunogenic tumor that arises in
chronically inflamed livers due to underlying chronic liver disease caused by viral and non …

Cases of hepatocellular carcinoma (HCC) are rapidly rising. This is particularly the case in
the Western world, as a result of increasing rates of chronic liver disease, secondary to …

With mortality rates of liver cancer doubling in the last 20 years, this disease is on the rise
and has become the fifth most common cancer in men and the seventh most common …